Govaere, Olivier; Hasoon, Megan; Alexander, Leigh et al.
A proteo-transcriptomic map of non-alcoholic fatty liver disease signaturesNATURE METABOLISM. Bd. 5. H. 4. 2023 S. 572-+
Newsome, Philip N.; Sanyal, Arun J.; Neff, Guy et al.
A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitisNATURE COMMUNICATIONS. Bd. 14. H. 1. 2023
Uche, Chukwudumebi S.; Zaman, Saif; Sreeram, Kashyap et al.
A RULES-BASED ALGORITHM FOR EXTRACTING STRUCTURED CLINICAL DATA FROM LIVER CT FREE-TEXT RADIOLOGY REPORTSGASTROENTEROLOGY. Bd. 164. H. 6. 2023 S. S1401-S1402
Lazarus, Jeffrey; Alazawi, William; Basuroy, Ron et al.
A social media listening study of patients' experiences toward NAFLD (LISTEN-NAFLD)JOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S612-S612
Ashfaq, Aqsa; Meineck, Myriam; Pautz, Andrea et al.
A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathyPHARMACOLOGY & THERAPEUTICS. Bd. 249. 2023
Jonasson, Elise; Ostberg, Nadja; Gairing, Simon Johannes et al.
A Validation of the Bilirubin-Albumin-Betablocker-Statin Score to Predict the Development of Hepatic Encephalopathy in Patients With Liver CirrhosisAMERICAN JOURNAL OF GASTROENTEROLOGY. Bd. 118. H. 9S. 2023 S. S25-S26
Gairing, Simon Johannes; Schleicher, Eva Maria; Kaps, Leonard et al.
A virtual reality-driving test to predict car accidents in patients with cirrhosisJOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S264-S265
Armandi, Angelo; Liguori, Antonio; Merizian, Talal et al.
Accuracy of 100 Hz transient elastography-based spleen stiffness for the identification of advanced fibrosis in biopsy-proven nonalcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S654-S655
Armandi, Angelo; Sanavia, Tiziana; Vanderschueren, Emma et al.
ACCURACY OF A DEDICATED 100 HZ VIBRATION-CONTROLLED SPLEEN STIFFNESS MEASUREMENT VERSUS BAVENO CRITERIA FOR THE DETECTION OF VARICES IN PATIENTS WITH COMPENSATED CIRRHOSISHEPATOLOGY. Bd. 78. 2023 S. S1434-S1435
Weber, M. M. M.; Apostolidis, L.; Krug, S. et al.
Activity and safety of avelumab alone or in combination with cabozantinib in patients with advanced high grade neuroendocrine neoplasias (NEN G3) progressing after chemotherapy. The phase II, open-label, multicenter AVENEC and CABOAVENEC trialsANNALS OF ONCOLOGY. Bd. 34. 2023 S. S702-S702